vs

Side-by-side financial comparison of Digimarc CORP (DMRC) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $8.9M, roughly 1.5× Digimarc CORP). Digimarc CORP runs the higher net margin — -47.2% vs -488.0%, a 440.7% gap on every dollar of revenue. On growth, Digimarc CORP posted the faster year-over-year revenue change (2.9% vs -22.4%). Digimarc CORP produced more free cash flow last quarter ($895.0K vs $-57.1M). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -5.3%).

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

DMRC vs OCUL — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.5× larger
OCUL
$13.3M
$8.9M
DMRC
Growing faster (revenue YoY)
DMRC
DMRC
+25.3% gap
DMRC
2.9%
-22.4%
OCUL
Higher net margin
DMRC
DMRC
440.7% more per $
DMRC
-47.2%
-488.0%
OCUL
More free cash flow
DMRC
DMRC
$58.0M more FCF
DMRC
$895.0K
$-57.1M
OCUL
Faster 2-yr revenue CAGR
OCUL
OCUL
Annualised
OCUL
-5.3%
-5.3%
DMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DMRC
DMRC
OCUL
OCUL
Revenue
$8.9M
$13.3M
Net Profit
$-4.2M
$-64.7M
Gross Margin
63.5%
88.0%
Operating Margin
-48.2%
-526.5%
Net Margin
-47.2%
-488.0%
Revenue YoY
2.9%
-22.4%
Net Profit YoY
51.4%
-33.6%
EPS (diluted)
$-0.18
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMRC
DMRC
OCUL
OCUL
Q4 25
$8.9M
$13.3M
Q3 25
$7.6M
$14.5M
Q2 25
$8.0M
$13.5M
Q1 25
$9.4M
$10.7M
Q4 24
$8.7M
$17.1M
Q3 24
$9.4M
$15.4M
Q2 24
$10.4M
$16.4M
Q1 24
$9.9M
$14.8M
Net Profit
DMRC
DMRC
OCUL
OCUL
Q4 25
$-4.2M
$-64.7M
Q3 25
$-8.2M
$-69.4M
Q2 25
$-8.2M
$-67.8M
Q1 25
$-11.7M
$-64.1M
Q4 24
$-8.6M
$-48.4M
Q3 24
$-10.8M
$-36.5M
Q2 24
$-9.3M
$-43.8M
Q1 24
$-10.3M
$-64.8M
Gross Margin
DMRC
DMRC
OCUL
OCUL
Q4 25
63.5%
88.0%
Q3 25
58.3%
87.8%
Q2 25
58.8%
85.6%
Q1 25
65.0%
88.2%
Q4 24
60.8%
92.8%
Q3 24
62.4%
89.9%
Q2 24
66.1%
90.8%
Q1 24
62.5%
91.0%
Operating Margin
DMRC
DMRC
OCUL
OCUL
Q4 25
-48.2%
-526.5%
Q3 25
-109.7%
-472.3%
Q2 25
-105.2%
-502.6%
Q1 25
-128.9%
-597.5%
Q4 24
-105.1%
-296.1%
Q3 24
-120.4%
-298.2%
Q2 24
-96.2%
-265.1%
Q1 24
-109.2%
-214.0%
Net Margin
DMRC
DMRC
OCUL
OCUL
Q4 25
-47.2%
-488.0%
Q3 25
-106.9%
-477.3%
Q2 25
-102.6%
-503.9%
Q1 25
-125.2%
-598.7%
Q4 24
-99.9%
-283.3%
Q3 24
-113.9%
-236.6%
Q2 24
-89.3%
-266.3%
Q1 24
-104.0%
-438.9%
EPS (diluted)
DMRC
DMRC
OCUL
OCUL
Q4 25
$-0.18
$-0.27
Q3 25
$-0.38
$-0.38
Q2 25
$-0.38
$-0.39
Q1 25
$-0.55
$-0.38
Q4 24
$-0.40
$-0.25
Q3 24
$-0.50
$-0.22
Q2 24
$-0.43
$-0.26
Q1 24
$-0.50
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMRC
DMRC
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$12.9M
$737.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$40.2M
$654.3M
Total Assets
$53.0M
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMRC
DMRC
OCUL
OCUL
Q4 25
$12.9M
$737.1M
Q3 25
$12.6M
$344.8M
Q2 25
$16.1M
$391.1M
Q1 25
$21.6M
$349.7M
Q4 24
$28.7M
$392.1M
Q3 24
$33.7M
$427.2M
Q2 24
$41.5M
$459.7M
Q1 24
$48.9M
$482.9M
Stockholders' Equity
DMRC
DMRC
OCUL
OCUL
Q4 25
$40.2M
$654.3M
Q3 25
$41.4M
$258.2M
Q2 25
$46.5M
$305.9M
Q1 25
$50.0M
$265.9M
Q4 24
$61.4M
$315.3M
Q3 24
$70.2M
$352.0M
Q2 24
$77.2M
$377.7M
Q1 24
$84.5M
$408.0M
Total Assets
DMRC
DMRC
OCUL
OCUL
Q4 25
$53.0M
$808.1M
Q3 25
$55.4M
$410.9M
Q2 25
$60.7M
$451.3M
Q1 25
$66.5M
$405.9M
Q4 24
$75.8M
$457.9M
Q3 24
$85.0M
$490.4M
Q2 24
$93.4M
$517.1M
Q1 24
$99.7M
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMRC
DMRC
OCUL
OCUL
Operating Cash FlowLast quarter
$991.0K
$-54.2M
Free Cash FlowOCF − Capex
$895.0K
$-57.1M
FCF MarginFCF / Revenue
10.0%
-430.9%
Capex IntensityCapex / Revenue
1.1%
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMRC
DMRC
OCUL
OCUL
Q4 25
$991.0K
$-54.2M
Q3 25
$-2.6M
$-50.7M
Q2 25
$-4.7M
$-55.2M
Q1 25
$-5.5M
$-44.7M
Q4 24
$-4.2M
$-39.4M
Q3 24
$-7.1M
$-36.6M
Q2 24
$-6.8M
$-24.8M
Q1 24
$-8.4M
$-33.9M
Free Cash Flow
DMRC
DMRC
OCUL
OCUL
Q4 25
$895.0K
$-57.1M
Q3 25
$-2.8M
$-56.7M
Q2 25
$-4.9M
$-56.5M
Q1 25
$-5.5M
$-46.6M
Q4 24
$-4.2M
$-39.6M
Q3 24
$-7.2M
$-36.6M
Q2 24
$-6.9M
$-25.5M
Q1 24
$-8.5M
$-34.1M
FCF Margin
DMRC
DMRC
OCUL
OCUL
Q4 25
10.0%
-430.9%
Q3 25
-36.9%
-390.0%
Q2 25
-61.0%
-419.7%
Q1 25
-59.1%
-435.6%
Q4 24
-49.1%
-232.0%
Q3 24
-75.7%
-237.6%
Q2 24
-66.1%
-155.4%
Q1 24
-85.8%
-231.1%
Capex Intensity
DMRC
DMRC
OCUL
OCUL
Q4 25
1.1%
21.4%
Q3 25
2.9%
41.2%
Q2 25
2.5%
9.3%
Q1 25
0.6%
18.1%
Q4 24
0.2%
1.2%
Q3 24
0.7%
0.6%
Q2 24
0.3%
4.5%
Q1 24
1.1%
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

OCUL
OCUL

Segment breakdown not available.

Related Comparisons